Sponsor Pipeline

Complement Therapeutics Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
2
Recruiting
Active Trials by Phase
Phase 1/2
1
Not specified
2
Active Trials
NCT IDTitleConditionStatus
Phase 1/2
NCT07392255 An Optimised GA Interventional Trial (Opti-GAIN) to Test if Treatment With CTx001 is Safe… Geographic Atrophy Secondary to Age-related Macular Degeneration Recruiting
Not specified
NCT07144137 A Non-Interventional Study Observing Short-Term Progression in Geographic Atrophy (GA) Geographic Atrophy Secondary to Age-related Macular Degeneration Recruiting
NCT05797896 Investigating Geographic Atrophy Insights (i-GAIN) Natural History Study Dry Age-related Macular Degeneration Active, Not Recruiting
Get alerts when Complement Therapeutics's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free